Phenotypic distinction in Enterococcus faecium and Enterococcus faecalis strains between susceptibility and resistance to growth-enhancing antibiotics
- PMID: 10508048
- PMCID: PMC89524
- DOI: 10.1128/AAC.43.10.2569
Phenotypic distinction in Enterococcus faecium and Enterococcus faecalis strains between susceptibility and resistance to growth-enhancing antibiotics
Abstract
Susceptibility of Enterococcus faecium and Enterococcus faecalis strains from animals and foods to growth-promoting antibiotics used in animal feed was tested by the agar dilution technique. Acquired resistance to bacitracin, narasin, tylosin, and virginiamycin was seen for both species, and for E. faecium, resistance to avilamycin and avoparcin was also seen. Drawing the distinction between susceptibility and resistance based on frequency distributions of MICs was easy with avoparcin, avilamycin, and tylosin but difficult with virginiamycin and to some extent also with bacitracin and narasin.
References
-
- Aarestrup F M. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomycin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals. Microb Drug Resist. 1998;4:137–141. - PubMed
-
- Barrière J C, Berthaud N, Beyer D, Dutka-Malen S, Paris J M, Desnottes J F. Recent developments in streptogramin research. Curr Pharm Des. 1998;4:155–180. - PubMed
-
- Bates J, Jordans J Z, Griffiths D T. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother. 1994;34:507–514. - PubMed
-
- Devriese L A, Pot B, Kersters K, Lauwers S, Haesebrouck F. Acidification of methyl-α-d-glucopyranoside: a useful test to differentiate Enterococcus casseliflavus and Enterococcus gallinarum from Enterococcus faecium species group and from Enterococcus faecalis. J Clin Microbiol. 1996;34:2607–2608. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
